Sean Pierce, DDS shares his journey from Yomi test drive to first case as a robotically-trained dental implant surgeon.
Video courtesy of Pierce Aesthetics.
by Lesa Francis
Implant surgery with robotic guidance – Digital workflows for patient care
Oral Health Magazine, June 2019
Bao-Thy N. Grant, DDS, Board-Certified Oral and Maxillofacial Robotic Surgeon at theCenter for Oral Reconstruction & Education
This article introduces Yomi-Enabled Surgery (“YES”) for dental implant therapy, including two case reports from early clinical experience of a board-certified oral and maxillofacial surgeon at the Center for Oral Reconstruction & Education, a full-scope oral and maxillofacial surgery private practice in Orange, California, USA.
“We believe that as oral surgeons embrace robotic surgery, through case planning accuracy, surgical precision, surgeon comfort, patient safety, and transformed surgical techniques, we can enhance patient care in our field.” – Bao-Thy N. Grant, DDS
New materials provide important enhancements to robot-assisted dental implant surgery workflow
Miami, FL, [January 7, 2019] — Neocis, Inc., the leader and innovator in dental implant surgery using advanced robotics, today announced a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for additional dental materials to use with Yomi. This clearance will expand workflow options to dental surgeons to achieve robot-assisted guidance.
Yomi, the first and only FDA cleared robot-assisted dental surgery system, provides computerized navigation to assist in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system offers physical guidance through haptic robotic technology, which constrains the drill in position, orientation, and depth. The assistive technology provides the surgeon with complete control and, unlike plastic surgical guides, allows for clear visualization of the surgical site.
Alon Mozes, PhD, Chief Executive Officer of Neocis stated, “Workflow options enabled by this new clearance offers more flexibility in the implementation of robot-assisted dental surgery and helps us to expand our reach to the more than four million dental implants performed in the U.S. each year. Workflow enhancements enabled by this new clearance are a direct result of our corporate commitment to the voice of the customer.”
“It has been great to work with Neocis as a Pioneer. This latest FDA clearance helps to provide me with even more workflow options for incorporating Yomi into my practice,” says Dr. Uday Reebye, oral surgeon in North Carolina and Yomi pioneer user.
Neocis previously received FDA clearance in February 2018 for a Chairside Splint to be used with Yomi, which enabled a same-day workflow that facilitated completion of dental implant surgery with robot-assisted guidance in a single visit.
About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Neocis Guidance System, or Yomi®, is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi® provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi® enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient. Learn more at neocismerge.wpengine.com.
Contact
Leigh Salvo or Carrie Mendivil
(415) 937-5404
investors@neocis.com
Christopher Sells Named Vice President, Sales and Marketing
Erik Beuckelaers Named Vice President, Finance & HR
Dennis Moses Named Vice President, Engineering
Miami, FL, [December 19, 2018] — Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced today the addition of three experienced leaders in the medical device industry to the Company’s management team.
- Christopher Sells has been named Vice President, Sales and Marketing. Sells most recently served as Vice President, New Business for Mazor Robotics where he was responsible for a number of key operational areas including new product launches and U.S. commercial optimization. He also served as Mazor’s Vice President of Sales as the company’s first U.S. employee. Previously, he held senior sales and operations roles with Hansen Medical, Intuitive Surgical, Neotonus, and Indigo Medical.
- Erik Beuckelaers has been named Vice President, Finance & HR. He most recently served as Head of Finance, IT and Facilities at Verb Surgical, Inc., the surgical robotics and digital surgery joint venture between Johnson & Johnson and Google. Previously, Beuckelaers held numerousroles at Johnson & Johnson over nearly 10 years, including roles as Acclarent Head of Finance and Janssen R&D Manager Immunology Portfolio Strategy.
- Dennis Moses has been named as Vice President, Engineering. Moses most recently served as Director of System Engineering for Verb Surgical, Inc. Prior, he served in numerous roles of increasing responsibility over nearly 15 years with Stryker Corporation. During his tenure, he participated in multiple major hardware and software releases and was successful in introducing and advancing a novel robotic solution for orthopedic surgery. Moses has led cross functional design and development efforts in various technologies and the medical device industry.
Mr. Sells, Mr. Beuckelaers, and Mr. Moses are part of the senior leadership team reporting directly to Alon Mozes, Chief Executive Officer.
“I am pleased to bring these strong executives to our senior management team during this pivotal stage in our company’s growth. Chris, Erik, and Dennis are all experienced industry leaders, each with a record of excellence and accomplishment in driving innovation, growth and operational improvements for a range of successful medical device and robotics companies. Following the addition of Dr. Fred Moll to the Neocis Board of Directors in July, we welcome the addition of these leaders who I am confident will add value as we change implant dentistry with the world’s first robot-assisted dental surgical system,” said Alon Mozes, Chief Executive Officer.
About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Neocis Guidance System, or Yomi®, is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi® provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi® enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient.
Contact
Leigh Salvo or Carrie Mendivil
(415) 937-5404
investors@neocis.com
Miami, FL, [November 14, 2018] — Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced today that it reached its first U.S. commercialization milestone with the sale of its 20th Yomi® surgical system.
“Following FDA clearance, we launched the ‘Pioneer Program’ in the U.S. to attract early adopters. I’m extremely pleased with the commercial adoption this program received, enabling us to execute our 20-system sales goal prior to our expected timeline,” said Alon Mozes, PhD, Chief Executive Officer.
Yomi systems purchased under this program were placed with a wide range of customers, including oral surgeons, periodontists, and general dental practices.
“Incorporating Yomi has forever changed the way I place implants. It’s a new level of precision and the next evolution in implant dentistry. Minimally invasive, robot-assisted surgery will soon be the new standard of care in implantology,” said Eddie Kotary, DMD.
There are more than four million dental implants performed each year in the U.S. Yet conventional surgery and drill guides fail to address many procedural challenges, such as invasive incisions and nerve damage from misplaced implants. In addition, dental implant surgeries are shifting from specialists to general dentists. Neocis’ Yomi surgical system provides the critical planning and guidance features that provide dental surgeons with the ability to gain real-time visual feedback and physical haptic guidance, which enables a minimally invasive flapless approach.
About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Neocis Guidance System, or Yomi®, is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi® provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi® enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient. Learn more at neocismerge.wpengine.com
Miami, FL, [November 14, 2018] — Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced today that it reached its first U.S. commercialization milestone with the sale of its 20th Yomi® surgical system.
“Following FDA clearance, we launched the ‘Pioneer Program’ in the U.S. to attract early adopters. I’m extremely pleased with the commercial adoption this program received, enabling us to execute our 20-system sales goal prior to our expected timeline,” said Alon Mozes, PhD, Chief Executive Officer.
Yomi systems purchased under this program were placed with a wide range of customers, including oral surgeons, periodontists, and general dental practices.
“Incorporating Yomi has forever changed the way I place implants. It’s a new level of precision and the next evolution in implant dentistry. Minimally invasive, robot-assisted surgery will soon be the new standard of care in implantology,” said Eddie Kotary, DMD.
There are more than four million dental implants performed each year in the U.S. Yet conventional surgery and drill guides fail to address many procedural challenges, such as invasive incisions and nerve damage from misplaced implants. In addition, dental implant surgeries are shifting from specialists to general dentists. Neocis’ Yomi surgical system provides the critical planning and guidance features that provide dental surgeons with the ability to gain real-time visual feedback and physical haptic guidance, which enables a minimally invasive flapless approach.
About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Neocis Guidance System, or Yomi®, is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi® provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi® enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient. Learn more at neocismerge.wpengine.com
Contact
Leigh Salvo or Carrie Mendivil
(415) 937-5404
leigh@gilmartinir.com